 Methotrexate histologic hepatic abnormalities meta-analysis STUDY OBJECTIVE risk liver toxicity long-term administration methotrexate patients rheumatoid arthritis psoriatic arthritis DESIGN meta-analysis studies relationship long-term low-dose methotrexate administration biopsy evidence liver fibrosis PATIENTS total patients studies RESULTS incidence progression liver disease worsening grade histologic classification Roenigk patients confidence intervals rate progression liver disease studies cumulative dose methotrexate Patients average confidence intervals chance histologic grade liver biopsy gram methotrexate overall incidence advanced pathologic changes liver biopsy grades IIIB IV patients confidence intervals development advanced histologic changes cumulative dose methotrexate history heavy drinkers alcohol week likely changes liver biopsy histologic progression Patients psoriasis likely patients rheumatoid arthritis changes histologic progression CONCLUSIONS risk liver toxicity patients long-term low-dose methotrexate therapy substantial risk increases total cumulative dose heavy consumption alcohol Heavy users alcohol long-term methotrexate therapy patients heavy users alcohol liver biopsies occurrence liver toxicity